Posted by on 2/11/2020 to
Here is an in depth, two year study regarding Lithium Orotate conducted by H. A. Nieper of Silbersee Clinic. "The specific principle is considered to be a directed intracellular transportation of lithium by means of the orotic carrier molecule, which has a high affinity for tissue dependent on the blood brain barrier. The directed carrier principle of the lithium orotate therapy makes a determination of the lithium level in blood serum unnecessary. The effectiveness of lithium therapy as such is based on a membranal and cellular displacement of sodium."
Also, the article, "The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis" is an interesting discussion regarding lithium and putative therapeutics to slow the progression of neuronal loss.
Hakala Research formulates and manufactures Lithium Orotate in a 10mg tablet. Click to purchase.
